N-Methyl-d-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95

Journal of Neurochemistry

Volumn 115, Issue 4, 2010, Pages 1045-1056

  Fan, Jing ^a   Vasuta, Oana Cristina ^a   Zhang, Lily Y J ^a,b   Wang, Liang ^a,b   George, Ashley ^a,b   Raymond, Lynn A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Desensitization; Excitotoxicity; Hippocampus; NMDA receptor; PSD 95; Striatum

Indexed keywords

MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; NR2B9C PROTEIN; POST SYNPATIC DENSITY 95; SCAFFOLD PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISSOCIATION; EMBRYO; EXCITOTOXICITY; HIPPOCAMPUS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRIA;

AMINO ACID SEQUENCE; ANIMALS; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; PEPTIDES; PROTEIN BINDING; PROTEIN SUBUNITS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 77958561819     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06994.x     Document Type: Article

References (57)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J. W., Wang Y. T., Salter M. W. and Tymianski M. (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298, 846-850.
2. Al-Hallaq R. A., Conrads T. P., Veenstra T. D. and Wenthold R. J. (2007) NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J. Neurosci. 27, 8334-8343.
3. Barria A. and Malinow R. (2002) Subunit-specific NMDA receptor trafficking to synapses. Neuron 35, 345-353.
4. Besancon E., Guo S., Lok J., Tymianski M. and Lo E. H. (2008) Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol. Sci. 29, 268-275.
5. Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
6. Cao J., Viholainen J. I., Dart C., Warwick H. K., Leyland M. L. and Courtney M. J. (2005) The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126.
7. Cavara N. A. and Hollmann M. (2008) Shuffling the deck anew: how NR3 tweaks NMDA receptor function. Mol. Neurobiol. 38, 16-26.
8. Chen N., Moshaver A. and Raymond L. A. (1997) Differential sensitivity of recombinant N-methyl-d-aspartate receptor subtypes to zinc inhibition. Mol. Pharmacol. 51, 1015-1023.
9. Chen Q., He S., Hu X. L. et al. (2007) Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J. Neurosci. 27, 542-552.
10. Christie J. M., Jane D. E. and Monaghan D. T. (2000) Native N-methyl-d-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites. J. Pharmacol. Exp. Ther. 292, 1169-1174.
11. Chung H. J., Huang Y. H., Lau L. F. and Huganir R. L. (2004) Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J. Neurosci. 24, 10248-10259.
12. Cousins S. L., Kenny A. V. and Stephenson F. A. (2009) Delineation of additional PSD-95 binding domains within NMDA receptor NR2 subunits reveals differences between NR2A/PSD-95 and NR2B/PSD-95 association. Neuroscience 158, 89-95.
13. Cui H., Hayashi A., Sun H. S. et al. (2007) PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J. Neurosci. 27, 9901-9915.
14. Cull-Candy S., Brickley S. and Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327-335.
15. Dingledine R., Borges K., Bowie D. and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
16. Von Engelhardt J., Coserea I., Pawlak V., Fuchs E. C., Kohr G., Seeburg P. H. and Monyer H. (2007) Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors. Neuropharmacology 53, 10-17.
17. Fan J., Cowan C. M., Zhang L. Y., Hayden M. R. and Raymond L. A. (2009) Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease. J. Neurosci. 29, 10928-10938.
18. Fujita A. and Kurachi Y. (2000) SAP family proteins. Biochem. Biophys. Res. Commun. 269, 1-6.
19. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M. and Calabresi P. (2006) A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J. Neurosci. 26, 2914-2922.
20. Gardoni F., Mauceri D., Malinverno M. et al. (2009) Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J. Neurosci. 29, 669-677.
21. Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R. J. and Morrison R. S. (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335-347.
22. Hamill O. P., Marty A., Neher E., Sakmann B. and Sigworth F. J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85-100.
23. Horn T. F., Wolf G., Duffy S., Weiss S., Keilhoff G. and MacVicar B. A. (2002) Nitric oxide promotes intracellular calcium release from mitochondria in striatal neurons. FASEB J. 16, 1611-1622.
24. Kim J. H., Liao D., Lau L. F. and Huganir R. L. (1998) SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20, 683-691.
25. Kim M. J., Dunah A. W., Wang Y. T. and Sheng M. (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745-760.
26. Kohr G. (2006) NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439-446.
27. Kornau H. C., Schenker L. T., Kennedy M. B. and Seeburg P. H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269, 1737-1740.
28. Krupp J. J., Vissel B., Heinemann S. F. and Westbrook G. L. (1996) Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 50, 1680-1688.
29. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B., Jr and Young A. B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15, 5297-5307.
30. Lau C. G. and Zukin R. S. (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426.
31. Lavezzari G., McCallum J., Dewey C. M. and Roche K. W. (2004) Subunit-specific regulation of NMDA receptor endocytosis. J. Neurosci. 24, 6383-6391.
32. Leveille F., El Gaamouch F., Gouix E., Lecocq M., Lobner D., Nicole O. and Buisson A. (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 4258-4271.
33. Li B., Chen N., Luo T., Otsu Y., Murphy T. H. and Raymond L. A. (2002) Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat. Neurosci. 5, 833-834.
34. Li L., Fan M., Icton C. D., Chen N., Leavitt B. R., Hayden M. R., Murphy T. H. and Raymond L. A. (2003) Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease. Neurobiol. Aging 24, 1113-1121.
35. Liu Y., Wong T. P., Aarts M. et al. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857.
36. Martin H. G. and Wang Y. T. (2010) Blocking the deadly effects of the NMDA receptor in stroke. Cell 140, 174-176.
37. Monyer H., Burnashev N., Laurie D. J., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
38. Niethammer M., Kim E. and Sheng M. (1996) Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16, 2157-2163.
39. Petralia R. S., Wang Y. X., Hua F., Yi Z., Zhou A., Ge L., Stephenson F. A. and Wenthold R. J. (2010) Organization of NMDA receptors at extrasynaptic locations. Neuroscience 167, 68-87.
40. Rothman S. M. and Olney J. W. (1995) Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci. 18, 57-58.
41. Rumbaugh G. and Vicini S. (1999) Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons. J. Neurosci. 19, 10603-10610.
42. Rumbaugh G., Adams J. P., Kim J. H. and Huganir R. L. (2006) SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc. Natl Acad. Sci. USA 103, 4344-4351.
43. Sans N., Prybylowski K., Petralia R. S., Chang K., Wang Y. X., Racca C., Vicini S. and Wenthold R. J. (2003) NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat. Cell Biol. 5, 520-530.
44. Sattler R. and Tymianski M. (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78, 3-13.
45. Sattler R., Xiong Z., Lu W. Y., Hafner M., MacDonald J. F. and Tymianski M. (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284, 1845-1848.
46. Segal M., Greenberger V. and Korkotian E. (2003) Formation of dendritic spines in cultured striatal neurons depends on excitatory afferent activity. Eur. J. Neurosci. 17, 2573-2585.
47. Shehadeh J., Fernandes H. B., Zeron Mullins M. M., Graham R. K., Leavitt B. R., Hayden M. R. and Raymond L. A. (2006) Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol. Dis. 21, 392-403.
48. Soriano F. X. and Hardingham G. E. (2007) Compartmentalized NMDA receptor signalling to survival and death. J. Physiol. 584, 381-387.
49. Soriano F. X., Martel M. A., Papadia S. et al. (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci. 28, 10696-10710.
50. Sornarajah L., Vasuta O. C., Zhang L., Sutton C., Li B., El-Husseini A. and Raymond L. A. (2008) NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95. J. Neurophysiol. 99, 3052-3062.
51. Tovar K. R. and Westbrook G. L. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180-4188.
52. Tu W., Xu X., Peng L. et al. (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140, 222-234.
53. Vanhoutte P. and Bading H. (2003) Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr. Opin. Neurobiol. 13, 366-371.
54. Wenzel A., Fritschy J. M., Mohler H. and Benke D. (1997) NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68, 469-478.
55. Zeron M. M., Hansson O., Chen N., Wellington C. L., Leavitt B. R., Brundin P., Hayden M. R. and Raymond L. A. (2002) Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849-860.
56. Zorumski C. F., Thio L. L., Clark G. D. and Clifford D. B. (1990) Blockade of desensitization augments quisqualate excitotoxicity in hippocampal neurons. Neuron 5, 61-66.
57. Zucker B., Luthi-Carter R., Kama J. A., Dunah A. W., Stern E. A., Fox J. H., Standaert D. G., Young A. B. and Augood S. J. (2005) Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Hum. Mol. Genet. 14, 179-189.